Jagsonpal Pharmaceuticals Ltd.
JAGSNPHARM Share PricePharmaceuticals & Drugs
₹218.09
2.3 (1.1%)
As on December 4, 2025
Exchange Scrips: BSE507789NSEJAGSNPHARMISININE048B01035
Market Cap ₹ 1,456 Cr
P/E Ratio 26.16
Dividend Yield 0.57 %
Performance
Market performance
Open215.75
High219.57
Volumes29,715
Prev218.09
Low213.58
As on2025-12-04
Historical performance
1 Year High301.65
3 Year High328.04
5 Year High328.04
1 Year Low192.85
3 Year Low109.44
5 Year Low23.24
Fundamentals
Company Valuation
Market Cap (₹Cr)
1,456
Face Value (₹)
2
P/E Ratio
26.16
Dividend Yield
0.57 %
Investment Returns
1 Year
-23.1%
3 Years
62.4%
5 Years
805.7%
10 Years
962.8%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 216.95 | Bullish |
| 10-DMA | 208.94 | Bullish |
| 20-DMA | 210.01 | Bullish |
| 50-DMA | 216.46 | Bullish |
| 100-DMA | 234.2 | Bearish |
| 200-DMA | 228.07 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | 3 | 3 | 3 | 3 | 3 |
| Domestic Investors | 2 | 2 | 2 | 2 | 2 |
| Public Investors | 24648 | 22894 | 21080 | 18466 | 15628 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 26.16.
- 3Y Stock Price CAGR of the stock is 17.7.
- The stock has a beta of 1.8.
- In the last financial year, the company had an EBITDA of ₹593 Million.
- The company generated revenue of ₹2687 Million in the previous financial year.
Jagsonpal Pharmaceuticals Ltd.
218.092.3 (1.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 779059.8
No. of Shares: 3572 (Approx)
Performance:-22.1%
P/L: ₹-220940.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
